ELZA contributed to the recent 2024 SAoO Annual Congress, held in Lucerne, Switzerland, with Prof. Farhad Hafezi giving multiple lectures and co-leading the Refractive Surgery Course.
In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements in epi-on crosslinking, as presented by Prof. Farhad Hafezi of the ELZA Institute at the Winter ESCRS meeting in Frankfurt, Germany.
The newspapers Tages-Anzeiger, Der Bund, and Basler Zeitung published a story on laser eye surgery complications, and featured ELZA’s Medical Director, Prof. Farhad Hafezi as the expert contributor to the article.
Prof. Hafezi flew to South Africa to attend OSSA 2024 and give presentations that showcased the latest innovations in corneal cross-linking and biomechanics assessments.
The ELZA Institute’s surgeons and researchers were in Frankfurt this month to present our latest research and results at Winter ESCRS 2024.
Expertscape continuously monitor the research output of all peer-reviewed publication on PubMed and rank the top researchers across all of Medicine. Currently, ELZA has #1, #2 and #5 for corneal cross-linking.
Let’s delve into the insightful presentations given by two of ELZA’s finest surgeons during ELZA at Swiss Ophthalmological Society (SSO)’s Swiss Eye Week 2024, highlighting the contributions of ELZA’s Medical Director, Prof. Farhad Hafezi and consultant glaucoma surgeon, Prof. Kaweh Mansouri on Wednesday, January 17th, 2024. The conference was held to educate Switzerland’s up and coming ophthalmology residents, and is a highly anticipated meeting each year. This year, the meeting was held at that Belvédère Strandhotel, Spiez.
A recent paper explores the groundbreaking technique of Femto-CAIRS for advanced keratoconus management and visual rehabilitation.
The Ophthalmologist’s “CXL: What’s New in 2023?” article explores advancements in corneal collagen crosslinking for treating keratoconus. ELZA’s Farhad Hafezi discusses how CXL has advanced to the current state of the art, and highlights new breakthroughs like sub400 and PACE.
New study reveals how accelerated PACK-CXL with riboflavin/UV-A or rose bengal/green light can be effective treatments for bacterial keratitis.
